The Effect of Fluticasone Nasal Spray on Patients with Chronic Rhinitis and Chronic Obstructive Pulmonary Disease
Preprint
- 12 April 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background: Although upper and lower respiratory tract diseases coexist, studies discussing the relationship between chronic rhinitis (CR) and chronic obstructive pulmonary disease (COPD) are limited. Fluticasone nasal sprays are common treatment options for patients with rhinitis. Therefore, we aimed to investigate the effects of fluticasone nasal spray on patients with both CR and COPD. Methods: A retrospective review was performed using data from former smokers with CR and COPD at China Medical University Hospital (CMUH). Based on their medication history, patients were allocated into Group A, who had received treatment with fluticasone nasal spray, and Group B, who had never received this treatment. Pulmonary function test results, including forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC), were collected for both groups before treatment and one year after treatment. Statistical analysis was performed to evaluate the impact of fluticasone nasal spray treatment on pulmonary function. Results: A total of 123 former smokers were included, with 62 patients in Group A and 61 patients in Group B. At the baseline, there was no significant difference in age, sex, and pulmonary function between the two groups. After one year of treatment, Group A showed an upward trend in pulmonary function, with FEV1 increasing from 1.613 ± 0.554 to 1.708 ± 0.675 (P < 0.05) and FVC increasing from 2.540 ± 0.694 to 2.670 ± 0.839 (P < 0.05). Whereas, Group B exhibited a downward trend in pulmonary function after one year, with FEV1 decreasing from 1.609 ± 0.554 to 1.544 ± 0.517 (P < 0.05) and FVC decreasing from 2.586 ± 0.665 to 2.495 ± 0.679 (P < 0.05). Conclusions: The use of fluticasone nasal spray can improve pulmonary function in former smokers with both CR and COPD. This finding supports the "one airway, one disease" theory.Keywords
All Related Versions
- Version 1, 2025-04-12, Preprints
- Published version: Journal of Clinical Medicine, 14 (11), 3637.
This publication has 27 references indexed in Scilit:
- Chronic Rhinitis Is a High-Risk Comorbidity for 30-Day Hospital Readmission of Patients with Asthma and Chronic Obstructive Pulmonary DiseaseThe Journal of Allergy and Clinical Immunology: In Practice, 2019
- Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPDNew England Journal of Medicine, 2014
- Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta‐analysisAllergy, 2013
- A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2008
- Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2007
- Upper airway symptoms and quality of life in chronic obstructive pulmonary disease (COPD)Respiratory Medicine, 2004
- Relationship between chronic nasal and respiratory symptoms in patients with COPDRespiratory Medicine, 2003
- The Epidemiology of Chronic Rhinosinusitis in CanadiansThe Laryngoscope, 2003
- Population‐based study of non‐infectious rhinitis in relation to occupational exposure, age, sex, and smokingAmerican Journal of Industrial Medicine, 2002
- Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40Journal of Clinical Epidemiology, 2001